Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Epithelial and stromal-specific immune pathway activation in the murine endometrium post-coitum.

Field SL, Cummings M, Orsi NM.

Reproduction. 2015 Aug;150(2):127-38. doi: 10.1530/REP-15-0087. Epub 2015 May 26.

PMID:
26015594
2.

Cytokines in ovarian folliculogenesis, oocyte maturation and luteinisation.

Field SL, Dasgupta T, Cummings M, Orsi NM.

Mol Reprod Dev. 2014 Apr;81(4):284-314. doi: 10.1002/mrd.22285. Epub 2013 Dec 13. Review.

PMID:
24273059
3.

A robust RNA integrity-preserving staining protocol for laser capture microdissection of endometrial cancer tissue.

Cummings M, McGinley CV, Wilkinson N, Field SL, Duffy SR, Orsi NM.

Anal Biochem. 2011 Sep 1;416(1):123-5. doi: 10.1016/j.ab.2011.05.009. Epub 2011 May 12.

PMID:
21624343
4.

Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse.

Burgoyne CH, Field SL, Brown AK, Hensor EM, English A, Bingham SL, Verburg R, Fearon U, Lawson CA, Hamlin PJ, Straszynski L, Veale D, Conaghan P, Hull MA, van Laar JM, Tennant A, Emery P, Isaacs JD, Ponchel F.

Ann Rheum Dis. 2008 Jun;67(6):750-7. Epub 2007 Jul 20.

PMID:
17644540
5.

Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia.

Ponchel F, Verburg RJ, Bingham SJ, Brown AK, Moore J, Protheroe A, Short K, Lawson CA, Morgan AW, Quinn M, Buch M, Field SL, Maltby SL, Masurel A, Douglas SH, Straszynski L, Fearon U, Veale DJ, Patel P, McGonagle D, Snowden J, Markham AF, Ma D, van Laar JM, Papadaki HA, Emery P, Isaacs JD.

Arthritis Res Ther. 2005;7(1):R80-92. Epub 2004 Nov 16.

6.

Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions.

Ponchel F, Toomes C, Bransfield K, Leong FT, Douglas SH, Field SL, Bell SM, Combaret V, Puisieux A, Mighell AJ, Robinson PA, Inglehearn CF, Isaacs JD, Markham AF.

BMC Biotechnol. 2003 Oct 13;3:18.

7.

Lupus antibody bivalency is required to enhance prothrombin binding to phospholipid.

Field SL, Chesterman CN, Dai YP, Hogg PJ.

J Immunol. 2001 May 15;166(10):6118-25.

8.

Dependence on prothrombin for inhibition of activated protein C activity by lupus antibodies.

Field SL, Chesterman CN, Hogg PJ.

Thromb Haemost. 2000 Dec;84(6):1132-3. No abstract available.

PMID:
11154135
9.

Recent insights into antiphospholipid antibody-mediated thrombosis.

Field SL, Brighton TA, McNeil HP, Chesterman CN.

Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):407-22. Review.

PMID:
10856978
10.

Lupus anticoagulants form immune complexes with prothrombin and phospholipid that can augment thrombin production in flow.

Field SL, Hogg PJ, Daly EB, Dai YP, Murray B, Owens D, Chesterman CN.

Blood. 1999 Nov 15;94(10):3421-31.

11.

Extracellular matrix is a source of mitogenically active platelet-derived growth factor.

Field SL, Khachigian LM, Sleigh MJ, Yang G, Vandermark SE, Hogg PJ, Chesterman CN.

J Cell Physiol. 1996 Aug;168(2):322-32.

PMID:
8707868
12.

Platelet-derived growth factor A-chain synthetic peptide inhibits human glioma xenograft proliferation in nude mice.

Khachigian LM, Field SL, Crouch R, Chesterman CN.

Anticancer Res. 1995 Mar-Apr;15(2):337-41.

PMID:
7763003
13.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk